Aidoc

Active#41 in Israel

Clinical AI

Healthtech›clinical AI

Founded2016

HQTel Aviv

RaisedUSD 500M+

Last roundSeries E · Apr 2026

Country of originIsraelListed in the Israel ranking

Where would you invest?US operations in New YorkJurisdiction as cited by the ranking

Uback rankings

How the AI ranks →

Ranking	Tier	Rank	Edition	Next update
Israel · all sectors	Top 50	#41	Edition 0 – beta · October 2026	5 Oct 2026

Rank historyOct 2026 · #41First edition: no movements yet.

Estimated valuation

AI · Israel ranking

≈ USD 770MUSD 390M–1.5bn · Hundreds of M$ Low confidence

Hundreds of k$

Millions $

Tens of M$

Hundreds of M$

Unicorn

Decacorn

Hectocorn

Anchor: Last known equity round: Series E · USD 150M · Apr 2026
AI adjustment: None

An indicative editorial estimate produced by AI, imperfect by nature: neither a financial valuation nor investment advice. Only the market sets a company’s value. Method

Funding history

USD 500M+ raised in total

Date	Round	Amount	Type	Investors	Source
Apr 2026	Series E	USD 150M	Equity	Goldman Sachs Alternatives	fiercehealthcare.com

Rounds as cited by Uback’s rankings and their sources. Equity, debt and grants are shown separately; only equity rounds count towards the valuation anchor.

Independent analyses

By industry professionals & analysts

Industry professionals and financial analysts can publish their own analysis of Aidoc as a PDF, on one of three angles only:

ValuationWhat is Aidoc worth?

Versus competitorsIs #41 the right rank?

Who should acquire itStrategic buyers, and why

Publish an analysisName, role and LinkedIn shown · public sources only

Analyses are the opinion of their authors, not of Uback. They are checked before publication and never change the rank.

Invest

Back Aidoc whether or not it has agreed: your intention joins the pool on Aidoc, passed to the local partner once it reaches critical mass. Declaring an intention does not mean this company is raising funds.

Back Aidoc Or back healthtech in Israel

Pool on AidocBelow threshold

BackersBelow threshold

Paid intention · valid for life · movable until a deal process opens. If the company does not follow up, Uback invites its Backers to move their intentions to a competitor or a similar company. Investing in non-listed companies carries a risk of losing all the capital invested.

Do you run Aidoc?

Claim this profile to correct data, add your logo and description, or tell Uback about an upcoming round. Claiming never changes the rank.

Claim this profile Report an upcoming round → Report an error →

Are you a shareholder?

Considering selling some of your shares? Tell Uback privately. Nothing is published without your consent, and never a price or a volume.

Tell Uback privately

What the AI reads

Press & investor announcements1 source

Read by the AI at the next edition.

Comparable companies in Israel

Full Israel ranking →

ScaleOps#40Dev tools › cloud and GPU resource automationHundreds of M$Alice#42Cybersecurity › AI safety and securityHundreds of M$Port#39Dev tools › internal developer portalHundreds of M$Salt Security#43Cybersecurity › API securityHundreds of M$

Investors in Aidoc: Goldman Sachs Asset Management

Sources. fiercehealthcare.com

Last updated: Oct 2026Report an error

Uback is a content publisher. It provides no investment advice, receives no mandate and takes part in no transaction. Rankings, ranges and brackets are editorial estimates produced by AI, purely indicative.